Integrated Filing — IndAS



General information about company

Scrip Code 500027
NSE Symbol ATUL
MSEI Symbol NOTLISTED
ISIN INE100A01010
Name of company ATUL LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 23-01-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 26-12-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 23-01-2026   10:00:00
End date and time of board meeting 23-01-2026   14:10:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 1,57,362.00 4,60,347.00
Other income 3,859.00 11,333.00
Total income 1,61,221.00 4,71,680.00
2 Expenses
(a) Cost of materials consumed 74,415.00 2,36,386.00
(b) Purchases of stock-in-trade 2,871.00 7,096.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 5,337.00 (2,164.00)
(d) Employee benefit expense 16,673.00 40,787.00
(e) Finance costs 370.00 1,313.00
(f) Depreciation, depletion and amortisation expense 7,980.00 24,284.00
(f) Other Expenses
1 Power, fuel and water 14,865.00 47,856.00
2 Other Expenses 18,495.00 55,381.00
Total other expenses 33,360.00 1,03,237.00
Total expenses 1,41,006.00 4,10,939.00
3 Total profit before exceptional items and tax 20,215.00 60,741.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 20,215.00 60,741.00
6 Tax expense
7 Current tax 3,835.00 12,625.00
8 Deferred tax 159.00 727.00
9 Total tax expenses 3,994.00 13,352.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 16,221.00 47,389.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 133.00 438.00
16 Total profit (loss) for period 16,354.00 47,827.00
17 Other comprehensive income net of taxes (1,604.00) 6,921.00
18 Total Comprehensive Income for the period 14,750.00 54,748.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 16,074.00 46,775.00
Total profit or loss, attributable to non-controlling interests 280.00 1,052.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent (1,604.00) 6,921.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 2,944.00 2,944.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 54.6 158.87
Diluted earnings (loss) per share from continuing operations 54.6 158.87
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 54.6 158.87
Diluted earnings (loss) per share from continuing and discontinued operations 54.6 158.87
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on January 22, 2026 and approved by the Board of Directors in its meeting held on January 23, 2026. The Statutory Auditors have carried out a limited review of the consolidated unaudited financial results for the quarter nine months ended on December 31, 2025. Their limited review report does not have any modification.The Company has reported segment information as per the Ind AS 108, 'Operating Segments', as below: Name of segment Main product groups Life Science Chemicals Active pharmaceutical ingredients and its intermediates, crop protection chemicals Performance and Other Chemicals Adhesion promoters, bulk chemicals, epoxy resins and hardeners, intermediates, textile dyes Others Agribiotech, food products, services and others The Government of India has consolidated 29 existing labour legislations into a unified framework comprising four labour codes (the new labour codes) on November 21, 2025. Accordingly, the Group has assessed the impact of these changes and, based on certain estimates and an actuarial valuation, has made an incremental provision



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Life Science Chemicals 45,433.00 1,34,350.00
2 Performance and Other Chemicals 1,15,539.00 3,36,743.00
3 Ohters 1,865.00 6,130.00
Total Segment Revenue 1,62,837.00 4,77,223.00
Less: Inter segment revenue 5,475.00 16,876.00
Revenue from operations 1,57,362.00 4,60,347.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Life Science Chemicals 10,466.00 27,400.00
2 Performance and Other Chemicals 8,789.00 29,173.00
3 Ohters 309.00 1,058.00
Total Profit before tax 19,564.00 57,631.00
i. Finance cost 370.00 1,313.00
ii. Other Unallocable Expenditure net off Unallocable income (1,154.00) (4,423.00)
Profit before tax 20,348.00 60,741.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Life Science Chemicals 1,31,814.00 1,31,814.00
2 Performance and Other Chemicals 3,75,463.00 3,75,463.00
3 Ohters 24,540.00 24,540.00
Total Segment Asset 5,31,817.00 5,31,817.00
Un-allocable Assets 2,29,227.00 2,29,227.00
Net Segment Asset 7,61,044.00 7,61,044.00
4 Segment Liabilities
Segment Liabilities
1 Life Science Chemicals 28,211.00 28,211.00
2 Performance and Other Chemicals 83,566.00 83,566.00
3 Ohters 2,370.00 2,370.00
Total Segment Liabilities 1,14,147.00 1,14,147.00
Un-allocable Liabilities 33,341.00 33,341.00
Net Segment Liabilities 1,47,488.00 1,47,488.00
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on January 22, 2026 and approved by the Board of Directors in its meeting held on January 23, 2026. The Statutory Auditors have carried out a limited review of the consolidated unaudited financial results for the quarter nine months ended on December 31, 2025. Their limited review report does not have any modification.The Company has reported segment information as per the Ind AS 108, 'Operating Segments', as below: Name of segment Main product groups Life Science Chemicals Active pharmaceutical ingredients and its intermediates, crop protection chemicals Performance and Other Chemicals Adhesion promoters, bulk chemicals, epoxy resins and hardeners, intermediates, textile dyes Others Agribiotech, food products, services and others The Government of India has consolidated 29 existing labour legislations into a unified framework comprising four labour codes (the new labour codes) on November 21, 2025. Accordingly, the Group has assessed the impact of these changes and, based on certain estimates and an actuarial valuation, has made an incremental provision



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Fair value of equity instruments through other comprehensive income (2,441.00) 6,140.00
2 Remeasurement gain/ (loss) on defined benefit plans 169.00 235.00
Total Amount of items that will not be reclassified to profit and loss (2,272.00) 6,375.00
2 Income tax relating to items that will not be reclassified to profit or loss (306.00) 1,003.00
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gain/ (loss) on cash flow hedges 19.00 0.00
2 Exchange differences on transiation of foreign operations 360.00 1,646.00
Total Amount of items that will be reclassified to profit and loss 379.00 1,646.00
4 Income tax relating to items that will be reclassified to profit or loss 17.00 97.00
5 Total Other comprehensive income (1,604.00) 6,921.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Deloitte Haskins and Sells LLP Yes 31-07-2027